Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Fasitibant Low Dose
Total, all-cause mortality	Fasitibant Intermediate Dose
Total, all-cause mortality	Fasitibant High Dose
Total, all-cause mortality	PLACEBO
Total, other adverse events	Fasitibant Low Dose	28	110
Total, other adverse events	Fasitibant Intermediate Dose	46	110
Total, other adverse events	Fasitibant High Dose	36	108
Total, other adverse events	PLACEBO	44	107
Total, serious adverse events	Fasitibant Low Dose	2	110
Total, serious adverse events	Fasitibant Intermediate Dose	2	110
Total, serious adverse events	Fasitibant High Dose	2	108
Total, serious adverse events	PLACEBO	4	107

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02205814/event-totals